Jeffrey Crawford

8PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2026
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

|May 28, 2025
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.

|Nov 20, 2023
A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia.

Jeffrey Crawford, Roberto A Calle, Susie M Collins

|Jun 12, 2023
Adapting to Change: A Thoracic Oncology Team's Perspective.

Jeffrey Crawford, Susan Blackwell, Sally Yowell Barbour

|Oct 21, 2022
Associations between body mass index, weight loss and overall survival in patients with advanced lung cancer.

Cameron Oswalt, Yingzhou Liu, Herbert Pang

|May 11, 2021
Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-Analysis.

Carrie M Nielson, Lauren C Bylsma, Jon P Fryzek

Pageof 2

Frequent Collaborators

1 joint publications

Carrie M Nielson

1 joint publications

Lauren C Bylsma

1 joint publications

Roberto A Calle

1 joint publications

Susie M Collins